Skip to content
Research Article Open access CC BY 4.0

Geriatric Poly-Pharmacy: A Growing Epidemic. How to Prevent It?

Sonali Sarkar

Journal of Advances in Medicine and Medical Research · pp. 1–11 · Published 24 Apr 2017

10.9734/BJMMR/2017/32944

Abstract

Introduction: Geriatric poly-pharmacy is defined as the use of more drugs in older adults than are medically necessary. It is widely prevalent in clinical practice. The rationale for poly-pharmacy in the elderly is not clear. Objective: 1) Review the epidemiology, etiologic factors and potential consequences of geriatric poly-pharmacy; 2) Provide recommendations for prevention and reduction of geriatric poly-pharmacy. Methods: A review of literature for published articles in English language from online databases (Medline, EBSCO, Psychinfo, Google scholar) was conducted from 2000-2017. Results: With minor geographical variation, the prevalence of geriatric poly-pharmacy ranges from 15-80%. The trend is rising globally. Etiology is not clear. Associated factors include demographic factors (advanced age, education, geographic variation, socio-economic status, insurance), comorbidities, health status, severity of disease, treatment- refractoriness, healthcare setting (inpatient, out-patient or nursing home), cultural beliefs, physician prescribing pattern, etc. The concurrent administration and use of multiple medications increase the risk of drug interactions, potential adverse consequences, falls, fractures including morbidity and mortality in the elderly. Geriatric poly-pharmacy is also associated with cumulative toxicity, poor medication adherence and treatment non-compliance. Recommendations provided are targeted at preventing and reducing unnecessary geriatric poly-pharmacy in clinical practice. Conclusion: The growing epidemic of geriatric poly-pharmacy poses a significant public health problem. This article highlights on the strategies for preventing and reducing unnecessary prescribing of drugs in the elderly. A better understanding of physicians’ rationale for geriatric poly-pharmacy, patient tolerability and effectiveness of this strategy is needed to guide clinicians and to inform the development of evidence based treatment guidelines.

Geriatric poly-pharmacy elderly epidemiology etiology consequences

Cited by 8

Medication adherence in geriatric patients attending medical outpatient department

Oluremi A. Odubanjo, Brent Tipping, Lara S. Greenstein · South African Family Practice · 2024

Managing polypharmacy through medication review tools – pros and cons

Evelina Gavazova, Radiana Staynova, Daniela Grekova-Kafalova · Folia Medica · 2024

Determinants and consequences of polypharmacy in patients with a depressive disorder in later life

Carlijn Wiersema, Richard C. Oude Voshaar, Rob H. S. van den Brink · Acta Psychiatrica Scandinavica · 2022

A Critical View over the Newest Antidiabetic Molecules in Light of Efficacy—A Systematic Review and Meta-Analysis

Teodor Salmen, Liviu-Ionut Serbanoiu, Ioana-Cristina Bica · International Journal of Molecular Sciences · 2023

Physicians’ role in the development of inappropriate polypharmacy among older adults in Iran: a qualitative study

Seyede Salehe Mortazavi, Mohsen Shati, Seyed Kazem Malakouti · BMJ Open · 2019

Showing 7 of 8 known citations — external sources report more than can currently be individually listed.

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

8

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.